The effect of memantine in harmaline-induced tremor and neurodegeneration.

Essential tremor (ET) is one of the most common and most disabling movement disorders among adults. The drug treatment of ET remains unsatisfactory. Additional therapies are required for patients with inadequate response or intolerable side effects.

Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease.

Background: There is conflicting evidence as to whether Alzheimer disease (AD) is accompanied by loss of retinal ganglion cells. To evaluate this issue, we have used optical coherence tomography (OCT) to assess the thickness and volume of the retina. We have also sought to correlate our findings with visual function and cognitive impairment.

Fibrous dysplasia of the cranial bones: a case report and review of the literature.

Fibrous dysplasia (FD) is a relatively uncommon disorder that affects primarily the cranial region; its occurrence in the cranial base in combination with hindbrain herniation and aneurysmal bone cyst (ABC) constitutes an extremely rare condition. We report a case of polyostotic fibrous dysplasia with progressive occipital, temporal, and clival involvement. Clinical findings and differential diagnosis with special emphasis on the imaging features were discussed.

Posttraumatic stress disorder and major depressive disorder is common in parents of children with epilepsy.

Objective: The purpose of the study was to determine the prevalence of posttraumatic stress disorder (PTSD), posttraumatic stress symptoms (PTSS), and major depressive disorder (MDD) in parents of children with epilepsy.

Methods: Parents (77 mothers and 3 fathers) of children with epilepsy were administered the Structured Clinical Interview for DSM-IV (SCID), PTSD and MDD modules, and the General Health Questionnaire (GHQ).

Results: The prevalence of both PTSD and MDD was 31.

Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.

Botulinum toxin is a new method for treating masseteric hypertrophy, which offers many advantages over conventional surgical treatment. We describe the successful outpatient medical management of two patients with masseteric hypertrophy using botulinum toxin type A. No significant side effects occurred and the patients were satisfied cosmetically six months after the treatment.